SEC Form 4 · accession 0000899243-18-010091
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jake Bauer
Officer — See Remarks
Period of report
Apr 11, 2018
Accepted (ET)
Apr 12, 2018 · 8:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 11, 2018 | M | 5,000 | $12.25 | A | 66,777 | D | |
| Common Stock | Apr 11, 2018 | S | 5,000 | $50.00 | D | 61,777 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $12.25 | Apr 11, 2018 | M | 5,000 | D | — | Jan 17, 2027 | Common Stock | 5,000 | 49,850 | D |
Explanation of responses
- F1This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Remarks
Chief Business Officer